Lin‐Hai Yan
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 3
- Oncology 8
- Co-authors
- Yubo Xie (7 shared papers)Weiyuan Wei (6 shared papers)Wenlong Cao (5 shared papers)Qiang Xiao (5 shared papers)Ying Li (1 shared paper)Li Li (1 shared paper)Lu Lu (1 shared paper)Jiansi Chen (5 shared papers)
- Journals
- Journal of Cancer (3 papers)OncoTargets and Therapy (2 papers)World Journal of Gastroenterology (2 papers)Journal of Cellular Biochemistry (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Lin‐Hai Yan
22 papers receiving 304 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 146
- Molecular Biology 218
- Oncology 80
- Pathology and Forensic Medicine 28
- Cell Biology 19
Countries citing papers authored by Lin‐Hai Yan
This map shows the geographic impact of Lin‐Hai Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐Hai Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐Hai Yan more than expected).
Fields of papers citing papers by Lin‐Hai Yan
This network shows the impact of papers produced by Lin‐Hai Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐Hai Yan. The network helps show where Lin‐Hai Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin‐Hai Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 45 | |
| 2 | 2014 | 40 | |
| 3 | 2016 | 28 | |
| 4 | 2013 | 25 | |
| 5 | Targeting snoRNAs as an emerging method of therapeutic development for cancer. | 2019 | 22 |
| 6 | Overexpression of CDX2 in gastric cancer cells promotes the development of multidrug resistance. | 2015 | 21 |
| 7 | 2019 | 20 | |
| 8 | MTRR silencing inhibits growth and cisplatin resistance of ovarian carcinoma via inducing apoptosis and reducing autophagy. | 2015 | 20 |
| 9 | 2016 | 15 | |
| 10 | 2013 | 14 | |
| 11 | 2023 | 10 | |
| 12 | 2018 | 9 | |
| 13 | 2014 | 9 | |
| 14 | OX40 as a novel target for the reversal of immune escape in colorectal cancer. | 2021 | 9 |
| 15 | 2021 | 6 | |
| 16 | Consumptive hypothyroidism due to a gastrointestinal stromal tumor expressing type 3 iodothyronine deiodinase. | 2015 | 4 |
| 17 | 2025 | 3 | |
| 18 | 2009 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2018 | 2 |
About Lin‐Hai Yan
Lin‐Hai Yan is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Genetics, having authored 23 papers that have together received 310 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers), Digestive system and related health (4 papers), MicroRNA in disease regulation (3 papers), Epigenetics and DNA Methylation (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Research and Treatments (2 papers) and Gastrointestinal Tumor Research and Treatment (2 papers). The work is most often cited by research in Cancer Research (146 citations), Molecular Biology (218 citations), Oncology (80 citations), Pathology and Forensic Medicine (28 citations) and Cell Biology (19 citations). Lin‐Hai Yan has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Yubo Xie, Weiyuan Wei, Wenlong Cao, Qiang Xiao, Ying Li, Li Li, Lu Lu, Jiansi Chen, Xianwei Mo and Xiaoshi Zhang. Their work appears in journals such as Journal of Cancer, OncoTargets and Therapy, World Journal of Gastroenterology, Journal of Cellular Biochemistry and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.